Skip to main content

Immune Blistering Disorders

  • Chapter
Vulvar Disease

Abstract

Immune blistering diseases may involve the cutaneous or mucosal surfaces of the female genital structures. Blisters that form on mucosal surfaces erode quickly and appear more commonly as erosions. Diagnosis requires a thorough history and full examination of all cutaneous and mucosal sites to identify lesions that may be asymptomatic, healing, or hidden from view. Histology and direct immunofluorescence of a biopsy taken from the edge of a blister or erosion are necessary to diagnose and differentiate these diseases. An important characteristic is the location of blister formation: subepidermal or intraepidermal.

Management principles and recommended medications overlap for many of the immune blistering diseases; where specific differences exist, notations are made with the description of the disease. Systemic steroids or other immune-suppressive medication are often indicated. The use of topical steroids is occasionally sufficient and should be considered for vulvar skin lesions, especially in disease that is otherwise well-controlled. General care of the vulvar skin should include a review of basic guidelines with emphasis on soaks and barriers or skin protectants. Close follow-up and examination of cutaneous and mucosal surfaces are warranted for surveillance as many of these diseases are prone to recur.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013;381(9863):320–32.

    PubMed  Google Scholar 

  2. Bifulco G, Mandato VD, Piccoli R, Giampaolino P, Mignogna C, Mignogna MD, et al. Early invasive vulvar squamous cell carcinoma arising in a woman with vulvar pemphigus vulgaris and systemic lupus erythematosus. BMC Cancer. 2010;10:324.

    PubMed  PubMed Central  Google Scholar 

  3. Goldstein AT, Anhalt GJ, Klingman D, Burrows LJ. Mucous membrane pemphigoid of the vulva. Obstet Gynecol. 2005;105(5 Pt 2):1188–90.

    PubMed  Google Scholar 

  4. Huilaja L, Makikallio K, Hannula-Jouppi K, Vakeva L, Hook-Nikanne J, Tasanen K. Cyclosporine treatment in severe gestational pemphigoid. Acta Derm Venereol. 2015;95(5):593–5.

    PubMed  Google Scholar 

  5. Malakar S, Saha A. Successful treatment of resistant Lichen Planus Pemphigoides with cyclosporine: a new hope. Indian J Dermatol. 2016;61(1):112–4.

    PubMed  PubMed Central  Google Scholar 

  6. Antiga E, Caproni M. The diagnosis and treatment of dermatitis herpetiformis. Clin Cosmet Investig Dermatol. 2015;8:257–65.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Contestable JJ, Edhegard KD, Meyerle JH. Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment. Am J Clin Dermatol. 2014;15(6):517–24.

    PubMed  Google Scholar 

  8. Barbosa WS, Rodarte CM, Guerra JG, Maciel VG, Fleury Junior LF, Costa MB. Bullous systemic lupus erythematosus: differential diagnosis with dermatitis herpetiformis. An Bras Dermatol. 2011;86(4 Suppl 1):S92–5.

    PubMed  Google Scholar 

  9. Lebeau S, Mainetti C, Masouye I, Saurat JH, Borradori L. Localized childhood vulval pemphigoid treated with tacrolimus ointment. Dermatology. 2004;208(3):273–5.

    CAS  PubMed  Google Scholar 

  10. Gunther C, Wozel G, Meurer M, Pfeiffer C. Topical tacrolimus treatment for cicatricial pemphigoid. J Am Acad Dermatol. 2004;50(2):325–6.

    PubMed  Google Scholar 

  11. Howell E, Johnson SM. Venous thrombosis occurring after initiation of thalidomide for the treatment of cicatricial pemphigoid. J Drugs Dermatol. 2004;3(1):83–5.

    PubMed  Google Scholar 

  12. Nguyen T, Alraqum E, Razzaque Ahmed A. Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis. Int Immunopharmacol. 2015;26(1):1–3.

    PubMed  Google Scholar 

  13. Pipkin C. Erosive diseases of the vulva. Dermatol Clin. 2010;28(4):737–51.

    CAS  PubMed  Google Scholar 

  14. Lebeau S, Braun RP, Masouye I, Perrinaud A, Harms M, Borradori L. Acquired melanocytic naevus in childhood vulval pemphigoid. Dermatology. 2006;213(2):159–62.

    CAS  PubMed  Google Scholar 

  15. Urano S. Localized bullous pemphigoid of the vulva. J Dermatol. 1996;23(8):580–2.

    CAS  PubMed  Google Scholar 

  16. Levine V, Sanchez M, Nestor M. Localized vulvar pemphigoid in a child misdiagnosed as sexual abuse. Arch Dermatol. 1992;128(6):804–6.

    CAS  PubMed  Google Scholar 

  17. Stage AH, Humeniuk JM, Easley WK. Bullous pemphigoid of the vulva: a case report. Am J Obstet Gynecol. 1984;150(2):169–70.

    CAS  PubMed  Google Scholar 

  18. Ridley CM. Cicatricial pemphigoid of the vulva. Am J Obstet Gynecol. 1985;152(7 Pt 1):916–7.

    CAS  PubMed  Google Scholar 

  19. Leonard N, Biswas A, Hickey S, Bell H. Eosinophilic spongiosis in a case of lichen sclerosus: a marker for superimposed bullous pemphigoid? Histopathology. 2008;52(7):885–7.

    CAS  PubMed  Google Scholar 

  20. Farrell AM, Kirtschig G, Dalziel KL, Allen J, Dootson G, Edwards S, et al. Childhood vulval pemphigoid: a clinical and immunopathological study of five patients. Br J Dermatol. 1999;140(2):308–12.

    CAS  PubMed  Google Scholar 

  21. Marren P, Wojnarowska F, Venning V, Wilson C, Nayar M. Vulvar involvement in autoimmune bullous diseases. J Reprod Med. 1993;38(2):101–7.

    CAS  PubMed  Google Scholar 

  22. Wojnarowska F, Marsden RA, Bhogal B, Black MM. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol. 1988;19(5 Pt 1):792–805.

    CAS  PubMed  Google Scholar 

  23. Edwards S, Wojnarowska F, Armstrong LM. Chronic bullous disease of childhood with oral mucosal scarring. Clin Exp Dermatol. 1991;16(1):41–3.

    CAS  PubMed  Google Scholar 

  24. Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138(3):370–9.

    PubMed  Google Scholar 

  25. Edwards L, Hays S. Vulvar cicatricial pemphigoid as a lichen sclerosus imitator. A case report. J Reprod Med. 1992;37(6):561–4.

    CAS  PubMed  Google Scholar 

  26. Marren P, Walkden V, Mallon E, Wojnarowska F. Vulval cicatricial pemphigoid may mimic lichen sclerosus. Br J Dermatol. 1996;134(3):522–4.

    CAS  PubMed  Google Scholar 

  27. Hoque SR, Patel M, Farrell AM. Childhood cicatricial pemphigoid confined to the vulva. Clinical. Dermatology. 2005;31:63–4.

    Google Scholar 

  28. Sadik CD, Lima AL, Zillikens D. Pemphigoid gestationis: toward a better understanding of the etiopathogenesis. Clin Dermatol. 2016;34(3):378–82.

    PubMed  Google Scholar 

  29. Jenkins RE, Hern S, Black MM. Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol. 1999;24(4):255–9.

    CAS  PubMed  Google Scholar 

  30. Chi CC, Wang SH, Charles-Holmes R, Ambros-Rudolph C, Powell J, Jenkins R, et al. Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. Br J Dermatol. 2009;160(6):1222–8.

    PubMed  Google Scholar 

  31. Sitaru C, Powell J, Messer G, Brocker EB, Wojnarowska F, Zillikens D. Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis. Obstet Gynecol. 2004;103(4):757–63.

    PubMed  Google Scholar 

  32. Zaraa I, Mahfoudh A, Sellami MK, Chelly I, El Euch D, Zitouna M, et al. Lichen planus pemphigoides: four new cases and a review of the literature. Int J Dermatol. 2013;52(4):406–12.

    PubMed  Google Scholar 

  33. Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86.

    PubMed  PubMed Central  Google Scholar 

  34. Camisa C. Vesiculobullous systemic lupus erythematosus. A report of four cases. J Am Acad Dermatol. 1988;18(1 Pt 1):93–100.

    CAS  PubMed  Google Scholar 

  35. Miziara ID, Mahmoud A, Chagury AA, Alves RD. Bullous systemic lupus Erythematosus: case report. Int Arch Otorhinolaryngol. 2013;17(3):344–6.

    PubMed  PubMed Central  Google Scholar 

  36. Pinto-Sanchez MI, Bercik P, Verdu EF, Bai JC. Extraintestinal manifestations of celiac disease. Dig Dis. 2015;33(2):147–54.

    PubMed  Google Scholar 

  37. Malik M, Ahmed AR. Involvement of the female genital tract in pemphigus vulgaris. Obstet Gynecol. 2005;106(5 Pt 1):1005–12.

    PubMed  Google Scholar 

  38. Lopez-Jornet P, Bermejo-Fenoll A. Gingival lesions as a first symptom of pemphigus vulgaris in pregnancy. Br Dent J. 2005;199(2):91–2.

    CAS  PubMed  Google Scholar 

  39. Fairbanks Barbosa ND, de Aguiar LM, Maruta CW, Aoki V, Sotto MN, Labinas GH, et al. Vulvo-cervico-vaginal manifestations and evaluation of Papanicolaou smears in pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol. 2012;67(3):409–16.

    PubMed  Google Scholar 

  40. Kavala M, Topaloglu Demir F, Zindanci I, Can B, Turkoglu Z, Zemheri E, et al. Genital involvement in pemphigus vulgaris (PV): correlation with clinical and cervicovaginal pap smear findings. J Am Acad Dermatol. 2015;73(4):655–9.

    PubMed  Google Scholar 

  41. Batta K, Munday PE, Tatnall FM. Pemphigus vulgaris localized to the vagina presenting as chronic vaginal discharge. Br J Dermatol. 1999;140(5):945–7.

    CAS  PubMed  Google Scholar 

  42. Wieselthier JS, Pincus SH. Hailey-Hailey disease of the vulva. Arch Dermatol. 1993;129(10):1344–5.

    CAS  PubMed  Google Scholar 

  43. de Jesus LE, Dekermacher S, Manhaes CR, Faria LM, Barros ML. Acquired labial sinechiae and hydrocolpos secondary to Stevens-Johnson syndrome. Urology. 2012;80(4):919–21.

    PubMed  Google Scholar 

  44. Ting HC, Adam BA. Stevens-Johnson syndrome. A review of 34 cases. Int J Dermatol. 1985;24(9):587–91.

    CAS  PubMed  Google Scholar 

  45. Wain EM, Neill S. Fixed drug eruption of the vulva secondary to fluconazole. Clin Exp Dermatol. 2008;33(6):784–5.

    CAS  PubMed  Google Scholar 

  46. Fischer G. Vulvar fixed drug eruption. A report of 13 cases. J Reprod Med. 2007;52(2):81–6.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Colleen K. Stockdale .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Cite this chapter

Shaffer, S., Stockdale, C.K. (2019). Immune Blistering Disorders. In: Bornstein, J. (eds) Vulvar Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-61621-6_45

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-61621-6_45

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-61620-9

  • Online ISBN: 978-3-319-61621-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics